Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling
about
Latest progress in tyrosine kinase inhibitorsHuman Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells.Tissue-Specific Gain of RTK Signalling Uncovers Selective Cell Vulnerability during Embryogenesis.Tumor and Plasma Met Levels in Non-Metastatic Prostate Cancer.Proteoglycans and their roles in brain cancer.MET Inhibition in Clear Cell Renal Cell CarcinomaCharacterization of Heparan Sulfate Proteoglycan-positive Recycling Endosomes Isolated from Glioma Cells.Expression array analysis of the hepatocyte growth factor invasive program.Novel antagonists of heparin binding growth factors.Feedback regulation of RTK signaling in development.The interaction of heparan sulfate proteoglycans with endothelial transglutaminase-2 limits VEGF165-induced angiogenesis.
P2860
Q33576849-E18F6EAE-D4D3-44A8-B779-810E8D7002A5Q35762228-ED50F573-BE59-4A11-A15B-7E6B7AE02440Q35783030-B5AF7E8B-4D0F-45D8-AE38-AC5CCCEBAA29Q36051783-561BBF71-FE07-4CB8-B4C5-BD8F5BBD402AQ36816444-62C80FA0-959A-49BF-974C-F72726F3A5C0Q37067981-DA1FA58A-C9F5-4850-AA6B-B9ADA16E5E21Q38733794-73163730-9230-4754-8AC9-C460C611B756Q38847534-8ED3E16C-B5B8-486C-91AE-F1F841090E55Q43155853-D06DAF59-BA85-4FC1-9B3B-FC3E289BF3E5Q46578462-AE6F75AD-1CC2-49ED-A66F-D3DA2CB2A9EAQ50577776-1FB1BE8C-9842-4415-A727-2F700EF1858A
P2860
Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Targeted disruption of heparan ...... normal and oncogenic signaling
@ast
Targeted disruption of heparan ...... normal and oncogenic signaling
@en
Targeted disruption of heparan ...... normal and oncogenic signaling
@en-gb
Targeted disruption of heparan ...... normal and oncogenic signaling
@nl
type
label
Targeted disruption of heparan ...... normal and oncogenic signaling
@ast
Targeted disruption of heparan ...... normal and oncogenic signaling
@en
Targeted disruption of heparan ...... normal and oncogenic signaling
@en-gb
Targeted disruption of heparan ...... normal and oncogenic signaling
@nl
prefLabel
Targeted disruption of heparan ...... normal and oncogenic signaling
@ast
Targeted disruption of heparan ...... normal and oncogenic signaling
@en
Targeted disruption of heparan ...... normal and oncogenic signaling
@en-gb
Targeted disruption of heparan ...... normal and oncogenic signaling
@nl
P2093
P2860
P50
P3181
P1433
P1476
Targeted disruption of heparan ...... normal and oncogenic signaling
@en
P2093
Aykut Uren
Benedetta Peruzzi
C Andrew Fowler
Davida K Blackman
Fabiola Cecchi
Nicholas J Macdonald
R Andrew Byrd
Stephen J Stahl
P2860
P304
P3181
P356
10.1016/J.CCR.2012.06.029
P407
P577
2012-08-14T00:00:00Z